Search for Clinical Trial Results

Obsessive-Compulsive Disorder - 30 Studies Found
Status | Study |
Recruiting |
Study Name: Pharmacogenetic Study of Obsessive-Compulsive Disorder Condition: Obsessive-Compulsive Disorder Date: 2015-04-23 Interventions: Drug: SSRIs usual dose SSRI for obsessive-compulsive disorder, i.e. fluoxetine 40~80 mg dose equivalents |
Completed |
Study Name: Quetiapine Augmentation in Severe Obsessive Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2005-11-15 Interventions:
|
Completed |
Study Name: D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder Condition: Obsessive-compulsive Disorder Date: 2009-03-17 Interventions:
|
Completed |
Study Name: Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study Condition: Obsessive Compulsive Disorder Date: 2006-04-25 Interventions: Drug: Quetiapine |
Completed |
Study Name: Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2009-04-14 Interventions:
|
Completed |
Study Name: Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD) Condition: Obsessive-Compulsive Disorder Date: 2005-03-21 Interventions:
|
Recruiting |
Study Name: Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD) Condition: Obsessive Compulsive Disorder Date: 2005-09-14 Interventions:
|
Completed |
Study Name: Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder Condition: Obsessive-Compulsive Disorder Date: 2008-02-29 Interventions:
|
Completed |
Study Name: Ketamine Infusion for Obsessive-Compulsive Disorder Condition: Obsessive-compulsive Disorder Date: 2011-04-09 Interventions: Drug: ketamine Ketamine (a single 0.5mg intravenously over 40 minutes). |
Completed |
Study Name: Adjunctive Glycine for Obsessive Compulsive Disorder Condition: Obsessive Compulsive Disorder Date: 2006-11-28 Interventions:
|